+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Diabetic Foot Ulcers Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163264
The diabetic foot ulcers market size was valued at USD 6.32 Billion in 2024, driven by the rising incidence of diabetes across the 8 major markets. It is expected to grow at a CAGR of 5.85% during the forecast period of 2025-2034, with the values likely to reach USD 11.16 Billion by 2034.

Diabetic Foot Ulcers Market Overview

Diabetic foot ulcers are a medical condition characterized by wounds or sores on the feet and slow healing or non-healing because of poor blood or vascular circulation, or peripheral neuropathy in diabetic patients. These ulcers can prove disastrous if not well managed as they can cause infections, gangrene, and ultimately amputation. Since diabetes incidence is increasing worldwide, the management and handling of diabetic foot ulcers are emerging as an essential area of concern amongst researchers and major market players, leading to the advent of several innovative treatment alternatives.

Diabetic Foot Ulcers Market Growth Drivers

Rising Prevalence of Diabetes Boosts the Market Growth

The rising occurrence of diabetes is a key factor driving the market growth. In 2023, the International Diabetes Federation estimated that by 2045, 1 in 10 adults will be diagnosed with the disease for an overall of 783 million people across the globe. Over 90% of them will develop type 2 diabetes because of socio-economic, demographic, environmental, and genetics. Population growth, particularly in urban areas, rising elderly population, low physical activity, and higher prevalence of overweight and obesity are major drivers of the market growth.

Advancements in Wound Care to Meet Rising Diabetic Foot Ulcers Market Demand

It has been observed that the market for diabetic foot ulcers has expanded because of the progress in the technology of wound care such as advanced dressings and skin substitutes. Such technologies enhance the rate of healing, protect the patient from infections, and facilitate quicker recovery. Through the simulation of natural skin, the skin substitutes act as a barrier and promote tissue formation thereby improving the patients' results and fostering market growth.

Diabetic Foot Ulcers Market Trends

Emphasis on Early Diagnosis via Partnerships Between Market Players

In March 2023, Pune-based, Mylab Discovery Solutions, collaborated with the DnaNudge, a UK-based company, to launch a diabetic foot ulcer detection kit. This ground-breaking kit detects bacteria in infections and offers molecular antimicrobial resistance data in an hour. It allows doctors to define which antibiotic should be used for each individual and minimize the chances of antimicrobial resistance. This partnership is expected to help a large number of diabetic patients in India at risk of having their limbs amputated by diagnosing and managing them effectively for diabetic foot infections.

Telemedicine and Remote Monitoring to Enhance Diabetic Foot Ulcers Market Value

Telemedicine and wearable technology have revolutionized diabetic foot ulcer care by enabling remote monitoring, early detection of complications, and real-time treatment adjustments, enhancing patient convenience, reducing hospital visits, and improving treatment outcomes.

Adoption of Novel Therapeutics for Effective Management and Treatment

Alternative therapeutic methods, including stem cell and tissue engineering, are being increasingly applied in the treatment of diabetic foot ulcers. Such strategies enhance quicker healing of the wound as they trigger the formation of new tissue besides minimizing the possibility of an infection. They may represent an efficient treatment approach compared to conventional methods, especially in the case of chronic or nonhealing ulcers.

Preference for Personalized Medicine to Impact the Diabetic Foot Ulcers Market Size Positively

The adoption of personalised approaches targeting genetics, and medical records is one of the major market trends. This personalization of the treatment is aimed at enhancing the results thereby reducing the chances of negative side effects. It guarantees the client optimal treatment that is specific to their illness or disorder.

Diabetic Foot Ulcers Market Segmentation

“Diabetic Foot Ulcers Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Ulcer Type

  • Neuropathic Ulcer
  • Ischemic Ulcer
  • Neuro-ischemic Ulcer

Market Breakup by Product

  • Wound Care Dressings
  • Alginate Dressings
  • Hydrofiber Dressings
  • Surgical Dressings
  • Hydrogel Dressings
  • Foam Dressings
  • Film Dressings
  • Hydrocolloid Dressings
  • Biologics
  • Growth Factors
  • Skin Grafts
  • Therapy Devices
  • Negative Wound Pressure Therapy
  • Ultrasound Therapy
  • Antibiotic Medications
  • Others

Market Breakup by End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings

Market Breakup by Region

  • United States
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Japan
  • India

Diabetic Foot Ulcers Market Share

Market Segmentation Based on End User Set to Witness Substantial Growth

The market is divided into hospitals, clinics, ambulatory surgical centers, and home care settings based on the end user. Among these, hospitals are anticipated to have the largest market share as they provide vital mechanisms for well-established protocols and adequate human resources to handle complex operational conditions.

Diabetic Foot Ulcers Market by Region

Based on the region, the market report includes an insight into the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. Among these, the United States is expected to dominate the market due to the large healthcare spending and players in the pharmaceutical industry. Strong research activities and governmental measures to contribute to cancer research are some of the factors helping the market development in the region.

In the forecast period, India is expected to hold a significant market share, owing to an increasing health consciousness and betterment of medical facilities. This aspect may further enhance the demand for the market in the country due to a growing incidence of diabetes and the use of superior treatment methods.

Leading Players in the Diabetic Foot Ulcers Market

The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:

Smith & Nephew plc

Established in the year 1856 and headquartered in London, United Kingdom, the company specializes in the provision of advanced wound care dressings, negative pressure wound therapy devices, and skin substitutes. This is because the diabetic foot ulcer market is one of their core specialty areas as they concentrate on moist wound healing and infection prevention technologies to boost healing while at the same time minimizing complications.

ConvaTec Group

Founded in 1978 and based in the United Kingdom, they have a broad range of products like hydrocolloid dressings, foam dressings, and antimicrobial solutions that help provide the most suitable environment for diabetic foot ulcers. Their concern is fluid leakage and infection control, and both of these are important in patients with diabetes.

Molnlycke Health Care B.V.

Founded in 1849 and headquartered in Gothenburg, they deliver foam dressings along with antimicrobial dressings and advanced solutions for exudate management. Molnlycke underscores research and development, continuously innovating to elevate the management of chronic wounds, which includes diabetic foot ulcers.

Other companies include Solventum Corporation, Integra LifeSciences Holdings Corporation., Organogenesis Holdings Inc., MiMedx Group, Inc., Coloplast Group, and Essity Aktiebolag (publ).

Key Questions Answered in the Diabetic Foot Ulcers Market

  • What was the diabetic foot ulcers market value in 2024?
  • What is the diabetic foot ulcers market forecast outlook for 2025-2034?
  • What are the regional markets covered in the report?
  • What is the market breakup based on the ulcer type?
  • What is the market breakup based on the product?
  • What is the market segmentation based on the end user?
  • What major factors aid the diabetic foot ulcers market demand?
  • What are the market's major drivers, opportunities, and restraints?
  • Which regional market is expected to lead the market share in the forecast period?
  • Which country is expected to experience expedited growth during the forecast period?
  • What are the major diabetic foot ulcers market trends?
  • How does the rise in the geriatric population impact the market size?
  • Who are the key players in the diabetic foot ulcers market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
  • What is the primary cause of neuropathic ulcers in diabetic patients?
  • What are the key benefits of using wound care dressings in diabetic foot ulcers?
  • Why are hospitals the leading segment in diabetic foot ulcer care?
  • Why does the United States hold a significant share in the diabetic foot ulcer market?
  • What factors are driving the growth of the diabetic foot ulcer market in India?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Diabetic Foot Ulcers Market Overview: 8 Major Markets
3.1 Diabetic Foot Ulcers Market Historical Value (2018-2024)
3.2 Diabetic Foot Ulcers Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Diabetic Foot Ulcers: Disease Overview
5.1 Guidelines and Stages
5.2 Pathophysiology
5.3 Screening and Diagnosis
5.4 Therapy Pathway
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
6.3 Risk Assessment and Therapy Success Rate
7 Diabetic Foot Ulcers Market Epidemiology Scenario and Forecast - 8 Major Markets
7.1 8MM Epidemiology Scenario Overview (2018-2034)
7.1.1 Prevalence, by Country
7.1.1.1 United States
7.1.1.2 United Kingdom
7.1.1.3 EU4
7.1.1.4 India
7.1.1.5 Japan
7.1.2 Diagnosed Cases, by Country
7.1.2.1 United States
7.1.2.2 United Kingdom
7.1.2.3 EU4
7.1.2.4 India
7.1.2.5 Japan
7.1.3 Treatment Seeking Rate, by Country
7.1.3.1 United States
7.1.3.2 United Kingdom
7.1.3.3 EU4
7.1.3.4 India
7.1.3.5 Japan
8 Diabetic Foot Ulcers Market Landscape: 8 Major Markets*
8.1 Diabetic Foot Ulcers Market: Developers Landscape
8.1.1 Analysis by Year of Establishment
8.1.2 Analysis by Company Size
8.1.3 Analysis by Region
8.2 Diabetic Foot Ulcers Market: Product Landscape
8.2.1 Analysis by Type
8.2.2 Analysis by Product
9 Diabetic Foot Ulcers Market Challenges and Unmet Needs
9.1 Therapy Pathway Challenges
9.2 Compliance and Drop-Out Analysis
9.3 Awareness and Prevention Gaps
10 Cost of Treatment
11 Diabetic Foot Ulcers Market Dynamics
11.1 Market Drivers and Constraints
11.2 SWOT Analysis
11.2.1 Strengths
11.2.2 Weaknesses
11.2.3 Opportunities
11.2.4 Threats
11.3 PESTEL Analysis
11.3.1 Political
11.3.2 Economic
11.3.3 Social
11.3.4 Technological
11.3.5 Legal
11.3.6 Environment
11.4 Porter’s Five Forces Model
11.4.1 Bargaining Power of Suppliers
11.4.2 Bargaining Power of Buyers
11.4.3 Threat of New Entrants
11.4.4 Threat of Substitutes
11.4.5 Degree of Rivalry
11.5 Key Demand Indicators
11.6 Key Price Indicators
11.7 Industry Events, Initiatives, and Trends
11.8 Value Chain Analysis
12 Diabetic Foot Ulcers Market Segmentation: 8 Major Markets
12.1 Diabetic Foot Ulcers Market (2018-2034) by Ulcer Type
12.1.1 Market Overview
12.1.2 Neuropathic Ulcer
12.1.3 Ischemic Ulcer
12.1.4 Neuro-ischemic Ulcer
12.2 Diabetic Foot Ulcers Market (2018-2034) by Product
12.2.1 Market Overview
12.2.2 Wound Care Dressings
12.2.2.1 Alginate Dressings
12.2.2.2 Hydrofiber Dressings
12.2.2.3 Surgical Dressings
12.2.2.4 Hydrogel Dressings
12.2.2.5 Foam Dressings
12.2.2.6 Film Dressings
12.2.2.7 Hydrocolloid Dressings
12.2.3 Biologics
12.2.3.1 Growth Factors
12.2.3.2 Skin Grafts
12.2.4 Therapy Devices
12.2.4.1 Negative Wound Pressure Therapy
12.2.4.2 Ultrasound Therapy
12.2.5 Antibiotic Medications
12.2.6 Others
12.3 Diabetic Foot Ulcers Market (2018-2034) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Clinics
12.3.4 Ambulatory Surgical Centers
12.3.5 Homecare Settings
12.4 Diabetic Foot Ulcers Market (2018-2034) by Region
12.4.1 Market Overview
12.4.2 United States
12.4.3 EU-4 and the United Kingdom
12.4.3.1 Germany
12.4.3.2 France
12.4.3.3 Italy
12.4.3.4 Spain
12.4.3.5 United Kingdom
12.4.4 Japan
12.4.5 India
13 United States Diabetic Foot Ulcers Market (2018-2034)
13.1 United States Diabetic Foot Ulcers Market Historical Value (2018-2024)
13.2 United States Diabetic Foot Ulcers Market Forecast Value (2025-2034)
13.3 United States Diabetic Foot Ulcers Market (2018-2034) by Ulcer Type
13.3.1 Market Overview
13.3.2 Neuropathic Ulcer
13.3.3 Ischemic Ulcer
13.3.4 Neuro-ischemic Ulcer
13.4 United States Diabetic Foot Ulcers Market (2018-2034) by Product
13.4.1 Market Overview
13.4.2 Wound Care Dressings
13.4.2.1 Alginate Dressings
13.4.2.2 Hydrofiber Dressings
13.4.2.3 Surgical Dressings
13.4.2.4 Hydrogel Dressings
13.4.2.5 Foam Dressings
13.4.2.6 Film Dressings
13.4.2.7 Hydrocolloid Dressings
13.4.3 Biologics
13.4.3.1 Growth Factors
13.4.3.2 Skin Grafts
13.4.4 Therapy Devices
13.4.4.1 Negative Wound Pressure Therapy
13.4.4.2 Ultrasound Therapy
13.4.5 Antibiotic Medications
13.4.6 Others
13.5 United States Diabetic Foot Ulcers Market (2018-2034) by End User
13.5.1 Market Overview
13.5.2 Hospitals
13.5.3 Clinics
13.5.4 Ambulatory Surgical Centers
13.5.5 Homecare Settings
14 EU-4 and United Kingdom Diabetic Foot Ulcers Market (2018-2034)
14.1 EU-4 and United Kingdom Diabetic Foot Ulcers Market Historical Value (2018-2024)
14.2 EU-4 and United Kingdom Diabetic Foot Ulcers Market Forecast Value (2025-2034)
14.3 EU-4 and United Kingdom Diabetic Foot Ulcers Market (2018-2034) by Ulcer Type
14.3.1 Market Overview
14.3.2 Neuropathic Ulcer
14.3.3 Ischemic Ulcer
14.3.4 Neuro-ischemic Ulcer
14.4 EU-4 and United Kingdom Diabetic Foot Ulcers Market (2018-2034) by Product
14.4.1 Market Overview
14.4.2 Wound Care Dressings
14.4.2.1 Alginate Dressings
14.4.2.2 Hydrofiber Dressings
14.4.2.3 Surgical Dressings
14.4.2.4 Hydrogel Dressings
14.4.2.5 Foam Dressings
14.4.2.6 Film Dressings
14.4.2.7 Hydrocolloid Dressings
14.4.3 Biologics
14.4.3.1 Growth Factors
14.4.3.2 Skin Grafts
14.4.4 Therapy Devices
14.4.4.1 Negative Wound Pressure Therapy
14.4.4.2 Ultrasound Therapy
14.4.5 Antibiotic Medications
14.4.6 Others
14.5 EU-4 and United Kingdom Diabetic Foot Ulcers Market (2018-2034) by End User
14.5.1 Market Overview
14.5.2 Hospitals
14.5.3 Clinics
14.5.4 Ambulatory Surgical Centers
14.5.5 Homecare Settings
15 Japan Diabetic Foot Ulcers Market (2018-2034)
15.1 Japan Diabetic Foot Ulcers Market Historical Value (2018-2024)
15.2 Japan Diabetic Foot Ulcers Market Forecast Value (2025-2034)
15.3 Japan Diabetic Foot Ulcers Market (2018-2034) by Ulcer Type
15.3.1 Market Overview
15.3.2 Neuropathic Ulcer
15.3.3 Ischemic Ulcer
15.3.4 Neuro-ischemic Ulcer
15.4 Japan Diabetic Foot Ulcers Market (2018-2034) by Product
15.4.1 Market Overview
15.4.2 Wound Care Dressings
15.4.2.1 Alginate Dressings
15.4.2.2 Hydrofiber Dressings
15.4.2.3 Surgical Dressings
15.4.2.4 Hydrogel Dressings
15.4.2.5 Foam Dressings
15.4.2.6 Film Dressings
15.4.2.7 Hydrocolloid Dressings
15.4.3 Biologics
15.4.3.1 Growth Factors
15.4.3.2 Skin Grafts
15.4.4 Therapy Devices
15.4.4.1 Negative Wound Pressure Therapy
15.4.4.2 Ultrasound Therapy
15.4.5 Antibiotic Medications
15.4.6 Others
15.5 Japan Diabetic Foot Ulcers Market (2018-2034) by End User
15.5.1 Market Overview
15.5.2 Hospitals
15.5.3 Clinics
15.5.4 Ambulatory Surgical Centers
15.5.5 Homecare Settings
16 India Diabetic Foot Ulcers Market (2018-2034)
16.1 India Diabetic Foot Ulcers Market Historical Value (2018-2024)
16.2 India Diabetic Foot Ulcers Market Forecast Value (2025-2034)
16.3 India Diabetic Foot Ulcers Market (2018-2034) by Ulcer Type
16.3.1 Market Overview
16.3.2 Neuropathic Ulcer
16.3.3 Ischemic Ulcer
16.3.4 Neuro-ischemic Ulcer
16.4 India Diabetic Foot Ulcers Market (2018-2034) by Product
16.4.1 Market Overview
16.4.2 Wound Care Dressings
16.4.2.1 Alginate Dressings
16.4.2.2 Hydrofiber Dressings
16.4.2.3 Surgical Dressings
16.4.2.4 Hydrogel Dressings
16.4.2.5 Foam Dressings
16.4.2.6 Film Dressings
16.4.2.7 Hydrocolloid Dressings
16.4.3 Biologics
16.4.3.1 Growth Factors
16.4.3.2 Skin Grafts
16.4.4 Therapy Devices
16.4.4.1 Negative Wound Pressure Therapy
16.4.4.2 Ultrasound Therapy
16.4.5 Antibiotic Medications
16.4.6 Others
16.5 India Diabetic Foot Ulcers Market (2018-2034) by End User
16.5.1 Market Overview
16.5.2 Hospitals
16.5.3 Clinics
16.5.4 Ambulatory Surgical Centers
16.5.5 Homecare Settings
17 Regulatory Framework
17.1 Regulatory Overview
17.2 US FDA
17.3 EU EMA
17.4 INDIA CDSCO
17.5 JAPAN PMDA
17.6 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication Year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Clinical Trial Analysis
19.1 Analysis by Trial Registration Year
19.2 Analysis by Trial Status
19.3 Analysis by Trial Phase
19.4 Analysis by Therapeutic Area
19.5 Analysis by Geography
20 Grant Analysis
20.1 Analysis by Year
20.2 Analysis by Amount Awarded
20.3 Analysis by Issuing Authority
20.4 Analysis by Grant Product
20.5 Analysis by Funding Institute
20.6 Analysis by Departments
20.7 Analysis by Recipient Organization
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Drug Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Strategic Initiatives
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Market Share by Top 5 Companies
23.2 Smith & Nephew plc.
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Company News and Developments
23.2.5 Certifications
23.3 ConvaTec Group
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Company News and Developments
23.3.5 Certifications
23.4 Molnlycke Health Care B.V.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Company News and Developments
23.4.5 Certifications
23.5 Solventum Corporation
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Company News and Developments
23.5.5 Certifications
23.6 Integra LifeSciences Holdings Corporation.
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Company News and Developments
23.6.5 Certifications
23.7 Organogenesis Holdings Inc.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Company News and Developments
23.7.5 Certifications
23.8 MiMedx Group, Inc.
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Company News and Developments
23.8.5 Certifications
23.9 Coloplast Group
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Company News and Developments
23.9.5 Certifications
23.10 Essity Aktiebolag (publ)
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Company News and Developments
23.10.5 Certifications
24 Diabetic Foot Ulcers Market - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Payment Methods (Additional Insight)
26.1 Government Funded
26.2 Private Insurance
26.3 Out-of-Pocket

Companies Mentioned

  • Smith & Nephew plc
  • ConvaTec Group
  • Molnlycke Health Care B.V.